Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis
BMJ global health, 2023•gh.bmj.com
Introduction Despite a growing body of research on the risks of SARS-CoV-2 infection during
pregnancy, there is continued controversy given heterogeneity in the quality and design of
published studies. Methods We screened ongoing studies in our sequential, prospective
meta-analysis. We pooled individual participant data to estimate the absolute and relative
risk (RR) of adverse outcomes among pregnant women with SARS-CoV-2 infection,
compared with confirmed negative pregnancies. We evaluated the risk of bias using a …
pregnancy, there is continued controversy given heterogeneity in the quality and design of
published studies. Methods We screened ongoing studies in our sequential, prospective
meta-analysis. We pooled individual participant data to estimate the absolute and relative
risk (RR) of adverse outcomes among pregnant women with SARS-CoV-2 infection,
compared with confirmed negative pregnancies. We evaluated the risk of bias using a …
Introduction
Despite a growing body of research on the risks of SARS-CoV-2 infection during pregnancy, there is continued controversy given heterogeneity in the quality and design of published studies.
Methods
We screened ongoing studies in our sequential, prospective meta-analysis. We pooled individual participant data to estimate the absolute and relative risk (RR) of adverse outcomes among pregnant women with SARS-CoV-2 infection, compared with confirmed negative pregnancies. We evaluated the risk of bias using a modified Newcastle-Ottawa Scale.
Results
We screened 137 studies and included 12 studies in 12 countries involving 13 136 pregnant women.
Pregnant women with SARS-CoV-2 infection—as compared with uninfected pregnant women—were at significantly increased risk of maternal mortality (10 studies; n=1490; RR 7.68, 95% CI 1.70 to 34.61); admission to intensive care unit (8 studies; n=6660; RR 3.81, 95% CI 2.03 to 7.17); receiving mechanical ventilation (7 studies; n=4887; RR 15.23, 95% CI 4.32 to 53.71); receiving any critical care (7 studies; n=4735; RR 5.48, 95% CI 2.57 to 11.72); and being diagnosed with pneumonia (6 studies; n=4573; RR 23.46, 95% CI 3.03 to 181.39) and thromboembolic disease (8 studies; n=5146; RR 5.50, 95% CI 1.12 to 27.12).
Neonates born to women with SARS-CoV-2 infection were more likely to be admitted to a neonatal care unit after birth (7 studies; n=7637; RR 1.86, 95% CI 1.12 to 3.08); be born preterm (7 studies; n=6233; RR 1.71, 95% CI 1.28 to 2.29) or moderately preterm (7 studies; n=6071; RR 2.92, 95% CI 1.88 to 4.54); and to be born low birth weight (12 studies; n=11 930; RR 1.19, 95% CI 1.02 to 1.40). Infection was not linked to stillbirth. Studies were generally at low or moderate risk of bias.
Conclusions
This analysis indicates that SARS-CoV-2 infection at any time during pregnancy increases the risk of maternal death, severe maternal morbidities and neonatal morbidity, but not stillbirth or intrauterine growth restriction. As more data become available, we will update these findings per the published protocol.
gh.bmj.com